Global Lab Monkeys (Laboratory Monkeys) Market Growth 2025-2031

The global Lab Monkeys (Laboratory Monkeys) market size is predicted to grow from US$ 2487 million in 2025 to US$ 3994 million in 2031; it is expected to grow at a CAGR of 8.2% from 2025 to 2031.

This report studies Lab Monkeys (Laboratory Monkeys), a kind of Non-human Primate. Nonhuman primates (NHPs). They are the closest animal models to humans regarding genetics, physiology and behavior. Monkeys are only used in animal experiments when other methods or animal species cannot be used. They are mainly used in studies of diseases of the brain, and in experiments for the development of vaccines or treatments of severe infectious diseases. Currently, the typical models of Lab Monkeys include Envigo (Inotiv)'s Cynomolgus macaques, HZ-Bio's Macaca Fascicularis and Rhesus Monkey, etc.

Market Overview:

The Lab Monkeys (Laboratory Monkeys) market is largely driven by the demand for Cynomolgus macaques and Rhesus monkeys, which account for the bulk of primates used in scientific research. While other species of monkeys are also used, these two types are most commonly used due to their availability, affordability, and physiological similarities to humans. The market is segmented by species (e.g., Cynomolgus macaques and Rhesus monkeys) and by application (e.g., Contract Research and Development Organizations (CROs), research institutions, and universities).

Cynomolgus Macaques: These are the most commonly used monkeys in medical and pharmaceutical research due to their smaller size, docile nature, and genetic resemblance to humans. They are often preferred for preclinical research, immunology studies, and vaccine testing.

Rhesus Monkeys: These monkeys are larger in size and more aggressive than Cynomolgus macaques, but they share a similar genetic structure with humans. They are often used in neuroscience research and brain function studies due to their cognitive and neurological similarities to humans.

The market is dominated by Contract Research Organizations (CROs), which provide comprehensive research and testing services for pharmaceutical companies and other stakeholders in the healthcare industry. Other major players in the market include research institutions, universities, and pharmaceutical companies, who rely on Lab Monkeys (Laboratory Monkeys)s to test and validate new treatments, drugs, and therapies.

Market Drivers:

Increased Demand for Biomedical Research and Drug Development

The primary driver for the growth of the Lab Monkeys (Laboratory Monkeys) market is the increasing demand for biomedical research and drug development. As the pharmaceutical industry expands, the need for non-human primates as models for preclinical research grows. Monkeys are crucial for understanding complex human diseases such as Alzheimer's, Parkinson's, HIV, and cancer, and are used extensively in drug safety testing, efficacy testing, and vaccine development.

For instance, the rapid development of vaccines for diseases such as COVID-19, Zika, and HIV has led to an increasing reliance on primates for testing and validation. As biopharmaceutical companies work to develop new therapeutics and vaccines, the need for high-quality, well-maintained Lab Monkeys (Laboratory Monkeys)s has increased significantly.

Rising Demand from Contract Research Organizations (CROs)

CROs are one of the largest consumer segments in the Lab Monkeys (Laboratory Monkeys) market. CROs provide outsourced research services to pharmaceutical and biotechnology companies, ranging from drug discovery to clinical trials. These organizations often rely on Lab Monkeys (Laboratory Monkeys)s for preclinical testing, including studies on drug toxicity, pharmacokinetics, and pharmacodynamics. As the demand for outsourcing drug development and research activities increases, so too does the need for experimental animals, particularly non-human primates like monkeys.

Increasing Focus on Personalized Medicine and Immunology

Another key driver of the Lab Monkeys (Laboratory Monkeys) market is the rise of personalized medicine and immunology. Personalized medicine focuses on tailoring medical treatment to individual patients based on their genetic makeup, and primates are used to model human genetic diversity and immune responses. Additionally, non-human primates are vital in immunology research, particularly in studies on the immune system’s response to pathogens and vaccines.

The demand for high-quality Lab Monkeys (Laboratory Monkeys)s will continue to rise as more pharmaceutical companies focus on personalized, genetically-driven treatments and more research is conducted in the fields of immunotherapy and gene therapy.

Market Restraints:

Ethical and Animal Welfare Concerns

One of the primary constraints on the growth of the Lab Monkeys (Laboratory Monkeys) market is the increasing concern over animal welfare and the ethics of using primates in scientific research. Non-human primates, especially those that are genetically similar to humans, are often seen as having higher cognitive and emotional capacities, which raises ethical concerns regarding their use in experiments. Public opinion and regulatory scrutiny regarding animal testing have been tightening globally, leading to stricter regulations on the use of primates in research.

Many countries and institutions have established stringent ethical guidelines to ensure that animal experiments are conducted humanely and that alternative methods are explored before resorting to primate research. These concerns have led to an increase in advocacy for alternative testing methods, such as in vitro testing and computer models, although these cannot fully replicate the complex biological systems that primates offer.

High Cost of Maintenance and Breeding

The high cost associated with breeding, maintaining, and housing Lab Monkeys (Laboratory Monkeys)s is another significant restraint. Primates are expensive to breed and care for, and their long gestation periods and high susceptibility to diseases make their maintenance particularly challenging. Ensuring the health and well-being of Lab Monkeys (Laboratory Monkeys)s requires significant financial and logistical resources, which may limit their widespread use in certain regions.

In addition, the breeding of genetically diverse and healthy monkeys for research purposes is a complex and expensive process. The cost of maintaining these monkeys in specialized environments with the necessary veterinary care and facilities further adds to the financial burden.

Limited Availability of High-Quality Monkeys

While the demand for Lab Monkeys (Laboratory Monkeys)s is high, the availability of high-quality, disease-free monkeys is limited. Primates are in short supply, particularly those that meet the high standards required for biomedical research. Ethical concerns, as well as the geographical location of breeding facilities, also limit the accessibility of monkeys for research purposes. This has led to price fluctuations and delays in the availability of monkeys for research, particularly in certain regions.

Regulatory Challenges

The use of Lab Monkeys (Laboratory Monkeys)s is heavily regulated by national and international laws. Different countries have different regulations regarding the use of non-human primates in scientific research. For example, the European Union has strict laws concerning animal testing, which limit the number of primates that can be used for research purposes. In contrast, the United States and other countries have more lenient regulations, although ethical and welfare concerns are still prominent. This regulatory landscape can limit the market for Lab Monkeys (Laboratory Monkeys)s, particularly in regions with stricter laws.

LP Information, Inc. (LPI) ' newest research report, the “Lab Monkeys (Laboratory Monkeys) Industry Forecast” looks at past sales and reviews total world Lab Monkeys (Laboratory Monkeys) sales in 2024, providing a comprehensive analysis by region and market sector of projected Lab Monkeys (Laboratory Monkeys) sales for 2025 through 2031. With Lab Monkeys (Laboratory Monkeys) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Lab Monkeys (Laboratory Monkeys) industry.

This Insight Report provides a comprehensive analysis of the global Lab Monkeys (Laboratory Monkeys) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Lab Monkeys (Laboratory Monkeys) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Lab Monkeys (Laboratory Monkeys) market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Lab Monkeys (Laboratory Monkeys) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Lab Monkeys (Laboratory Monkeys).

This report presents a comprehensive overview, market shares, and growth opportunities of Lab Monkeys (Laboratory Monkeys) market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Macaca Fascicularis (Cynomolgus Macaque)
Rhesus Monkey (Macaca Mulatta)
Others

Segmentation by Application:
Contract Research and Development Service Organization (CRO) Company
Scientific Research Institution
Colleges and Universities
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Vanny Bio Research
HZ-Bio
Envigo (Inotiv)
JOINN LABORATORIES
WuXi AppTec
Jingang Biotech
Charles River
Pharmaron
Xishan Zhongke
ONPRC (Oregon National Primate Research Center)
CNPRC (California National Primate Research Center)
Sichuan Hengshu Bio-Technolog
Topgene Biotechnology
Primate Products, Inc. (PPI)
Sichuan Green-House Biotech

Key Questions Addressed in this Report

What is the 10-year outlook for the global Lab Monkeys (Laboratory Monkeys) market?

What factors are driving Lab Monkeys (Laboratory Monkeys) market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Lab Monkeys (Laboratory Monkeys) market opportunities vary by end market size?

How does Lab Monkeys (Laboratory Monkeys) break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.


*This is a tentative TOC and the final deliverable is subject to change.*
1 Scope of the Report
2 Executive Summary
3 Global by Company
4 World Historic Review for Lab Monkeys (Laboratory Monkeys) by Geographic Region
5 Americas
6 APAC
7 Europe
8 Middle East & Africa
9 Market Drivers, Challenges and Trends
10 Manufacturing Cost Structure Analysis
11 Marketing, Distributors and Customer
12 World Forecast Review for Lab Monkeys (Laboratory Monkeys) by Geographic Region
13 Key Players Analysis
14 Research Findings and Conclusion

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings